Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
52 week high
|
Strong Performer, Getting Expensive
5850.5000
-16.50
(
-0.28
%)
NSE
Jan 13, 2026
14:43 PM
New 52W High today
Volume:
157.9K
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
20 May 2023
52 week high
5850.50
-0.28%
4Q - A Miss; Ends FY23 on weakest margins since past 5-years
Neutral:
Alkem Laboratories Ltd.
by
Motilal Oswal
Target: 3470
Target
Motilal Oswal
Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended
Market trades lower, ICICI Prudential Life Insurance's net profit grows 19% YoY in Q3
Trendlyne Marketwatch |
13 Jan 2026, 02:42PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
|
12 Jan 2026, 06:40PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021